Transcriptomic analysis of colistin-susceptible and colistin-resistant isolates identifies genes associated with colistin resistance in Acinetobacter baumannii

Clinical Microbiology and Infection

Volumn 21, Issue 8, 2015, Pages 765.e1-765.e7

  Park, Y K ^a,b   Lee, J Y ^a   Ko, K S ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea National Institute of Health   (South Korea)

Author keywords

Allelic replacement; Antibiotics; Lipopolysaccharide; mRNA sequencing; Quantitative RT PCR

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COLISTIN; GLYCOSYLTRANSFERASE; LIPID A; MEMBRANE PROTEIN; MESSENGER RNA; PHOSPHOETHANOLAMINE; POLY BETA 1,6 N ACETYLGLUCOSAMINE DEACETYLASE; PROTEIN PMRC; TRANSCRIPTOME; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL STRAIN; GENE IDENTIFICATION; HIGH THROUGHPUT SEQUENCING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; RNA SEQUENCE; TRANSCRIPTOMICS; ACINETOBACTER INFECTION; CHEMISTRY; COMPARATIVE STUDY; DNA SEQUENCE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS);

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION PROFILING; GENES, BACTERIAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIPID A; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84937525248     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.04.009     Document Type: Article

References (24)

1. Peleg A.Y., Hooper D.C. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010, 362:1804-1813.
2. Nation R.L., Li J. Colistin in the 21st century. Curr Opin Infect Dis 2009, 22:535-543.
3. Karaiskos I., Galani L., Baziaka F., Giamarellou H. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents 2013, 41:499-508.
4. Cai Y., Chai D., Wang R., Liang B., Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 2012, 67:1607-1615.
5. Sun S., Negrea A., Rhen M., Andersson D.I. Genetic analysis of colistin resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2009, 53:2298-2305.
6. Miller A.K., Brannon M.K., Stevens L., Andersson D.I. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother 2011, 55:5761-5769.
7. Adams M.D., Nickel G.C., Bajaksouzian S., Lavender H., Murthy A.R., Jacobs M.R., et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 2009, 53:3628-3634.
8. Park Y.K., Choi J.Y., Shin D., Ko K.S. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2011, 37:525-530.
9. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing, twenty-third informational supplement, M100-S23 2013, CLSI, Wayne, PA.
10. Song J.H., Ko K.S., Lee J.Y., Baek J.Y., Oh W.S., Yoon H.S., et al. Identification of essential genes in Streptococcus pneumoniae by allelic replacement mutagenesis. Mol Cells 2005, 19:365-374.
11. Newman J.R., Fuqua C. Broad-host-range expression vectors that carry the L-arabinose-inducible Escherichia coli araBAD promoter and the araC regulator. Gene 1999, 227:197-203.
12. Pelletier M.R., Casella L.G., Jones J.W., Adams M.D., Zurawski D.V., Hazlett K.R., et al. Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 2013, 57:4831-4840.
13. Gunn J.S., Lim K.B., Krueger J., Kim K., Guo L., Hackett M., et al. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 1998, 27:1171-1182.
14. Raetz C.R., Reynolds C.M., Trent M.S., Bishop R.E. Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 2007, 76:295-329.
15. Henry R., Vithanage N., Harrison P., Seemann T., Coutts S., Moffatt J.H., et al. Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine. Antimicrob Agents Chemother 2012, 56:59-69.
16. Luke N.R., Sauberan S.L., Russo T.A., Beanan J.M., Olson R., Loehfelm T.W., et al. Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infect Immun 2010, 78:2017-2023.
17. Smith R.L., O'Toole J.F., Maguire M.E., Sanders C.R. Membrane topology of Escherichia coli diacylglycerol kinase. J Bacteriol 1994, 176:5459-5465.
18. Walsh J.P., Bell R.M. Diacylglycerol kinase from Escherichia coli. Methods Enzymol 1992, 209:153-162.
19. Choi A.H., Slamti L., Avci F.Y., Pier G.B., Maira-Litran T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1,6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol 2009, 191:5953-5963.
20. Amini S., Goodarzi H., Tavazoie S. Genetic dissection of an exogenously induced biofilm in laboratory and clinical isolates of Escherichia coli. PLoS Pathog 2009, 5:e1000432.
21. Ramazzina I., Cendron L., Folli C., Berni R., Monteverdi D., Zanotti G., et al. Logical identification of an allantoinase analog (puuE) recruited from polysaccharide deacetylases. J Biol Chem 2008, 283:23295-23304.
22. Tamayo M., Santiso R., Otero F., Bou G., Lepe J.A., McConnell M.J., et al. Rapid determination of colistin resistance in clinical strains of Acinetobacter baumannii by use of the micromax assay. J Clin Microbiol 2013, 51:3675-3682.
23. Mitrophanov A.Y., Jewett M.W., Hadley T.J., Groisman E.A. Evolution and dynamics of regulatory architectures controlling polymyxin B resistance in enteric bacteria. PLoS Genetics 2008, 4:e1000233.
24. Beceiro A., Llobet E., Aranda J., Bengoechea J.A., Doumith M., Hornsey M., et al. Phosphoethanoleamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob Agents Chemother 2011, 55:3370-3379.